PCYC-1128-CA: A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

February 19, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02599324
Cancer - Renal Cell
Principal Investigator: Ding Wang, MD
Cancer, Renal Cancer, Phase 1, Phase I, Phase 2, Phase II, Renal Cell Carcinoma, Genitourinary tumors
Open